Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000026

Chief Medical Officer sold 106 shares at $15.01 ($1,591)

  • Chief Medical Officer acquired 106 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KREHER NERISSA · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-15 Exercise or conversion : show line 1 in the form +106 $2.10 $223 20,822 D
2022-09-15 Sale : show line 2 in the form −106 $15.01 $1,591 20,716 D
Open-market sales · 106 sh · avg $15.01 · $1,591

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-15 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −106 28,905 D
Loading xslF345X03/wf-form4_166361953637742.xml…